Insights

Innovative Portfolio Daiichi Sankyo focuses on developing advanced therapies, including antibody-drug conjugates for cancer treatment, representing high-value opportunities for suppliers and partners specializing in oncology drug manufacturing, R&D, and distribution.

Expansion Investments With recent investments exceeding $1 billion in Germany to enhance manufacturing capacity and development labs, there is a growing demand for supplier collaborations in high-tech pharmaceutical equipment, logistics, and construction services.

Strategic Collaborations Partnerships such as the joint development with Merck on antibody-drug conjugates and collaborations with BioMed X provide avenues to engage with innovative biotech firms and research organizations involved in cutting-edge oncology and cardiovascular therapies.

Market Engagement Active participation in events like the ESC Congress and breast cancer symposium highlights opportunities for medical communications, event sponsorship, and professional education solutions tailored to a global pharmaceutical audience.

Growth in Oncology A strong focus on becoming a key player in oncology within Europe, along with expanding drug pipelines, offers sales prospects for companies providing clinical trial services, specialized medical devices, and market access solutions for cancer treatments.

Daiichi Sankyo Europe GmbH Tech Stack

Daiichi Sankyo Europe GmbH uses 8 technology products and services including Veeam, Tableau, AutoCAD, and more. Explore Daiichi Sankyo Europe GmbH's tech stack below.

  • Veeam
    Backup And Recovery
  • Tableau
    Business Intelligence
  • AutoCAD
    Cad & Graphics
  • Unpkg
    Content Delivery Network
  • SAP R/3
    Enterprise Resource Planning
  • OneDrive
    File Sharing
  • HTML
    Programming Languages
  • Khoros
    Social Media Analytics And Monitoring

Media & News

Daiichi Sankyo Europe GmbH's Email Address Formats

Daiichi Sankyo Europe GmbH uses at least 1 format(s):
Daiichi Sankyo Europe GmbH Email FormatsExamplePercentage
First.Last@daiichi-sankyo.euJohn.Doe@daiichi-sankyo.eu
89%
FLast@daiichi-sankyo.euJDoe@daiichi-sankyo.eu
11%

Frequently Asked Questions

What is Daiichi Sankyo Europe GmbH's phone number?

Minus sign iconPlus sign icon
You can contact Daiichi Sankyo Europe GmbH's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Daiichi Sankyo Europe GmbH's official website and social media links?

Minus sign iconPlus sign icon
Daiichi Sankyo Europe GmbH's official website is daiichi-sankyo.eu and has social profiles on LinkedIn.

What is Daiichi Sankyo Europe GmbH's SIC code NAICS code?

Minus sign iconPlus sign icon
Daiichi Sankyo Europe GmbH's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Daiichi Sankyo Europe GmbH have currently?

Minus sign iconPlus sign icon
As of December 2025, Daiichi Sankyo Europe GmbH has approximately 1.2K employees across 4 continents, including EuropeAsiaNorth America. Key team members include Cio Of Europe & Global Head Of Business Relationship Management: A. B.Vice President Governmental Affairs & Strategic Partnerships Europe And Canada: M. F.Vice President Excellence And Innovation: P. G.. Explore Daiichi Sankyo Europe GmbH's employee directory with LeadIQ.

What industry does Daiichi Sankyo Europe GmbH belong to?

Minus sign iconPlus sign icon
Daiichi Sankyo Europe GmbH operates in the Pharmaceutical Manufacturing industry.

What technology does Daiichi Sankyo Europe GmbH use?

Minus sign iconPlus sign icon
Daiichi Sankyo Europe GmbH's tech stack includes VeeamTableauAutoCADUnpkgSAP R/3OneDriveHTMLKhoros.

What is Daiichi Sankyo Europe GmbH's email format?

Minus sign iconPlus sign icon
Daiichi Sankyo Europe GmbH's email format typically follows the pattern of First.Last@daiichi-sankyo.eu. Find more Daiichi Sankyo Europe GmbH email formats with LeadIQ.

When was Daiichi Sankyo Europe GmbH founded?

Minus sign iconPlus sign icon
Daiichi Sankyo Europe GmbH was founded in 1899.

Daiichi Sankyo Europe GmbH

Pharmaceutical ManufacturingBavaria, Germany1001-5000 Employees

Daiichi Sankyo is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people around the world by leveraging our world-class science and technology. 

In Europe, we want to become the benchmark for customer centricity in the areas we work in and a competitive player in Oncology. For these reasons we are constantly looking for new talents that are willing to deliver the best solutions to the various healthcare professionals who aim to provide their patients with the best possible therapy - whether in the cardiovascular or oncological field.

We know that our success in Europe relies on courageous people who seize opportunities and turn them into results. This is why we encourage our teams across Europe to be passionate about their objectives, challenge conventional thinking and share their local recipes for success and learnings with the whole company. It is only through their input, ideas and honest feedback that we can learn and leverage the full potential of our company.

In Europe we are operating in 13 countries. Because of our rather small size compared to larger pharmaceutical companies, each of our employees can have a huge impact – whether they work in the medical area, sales force, business intelligence or the IT department. This is why everybody at Daiichi Sankyo rolls up their sleeves and gets things done, even if this means that they sometimes have to go beyond their usual duties. 

If you would like to be an active member of our European family, we highly appreciate your application. Please take a look at our current vacancies. 

Imprint: https://www.daiichi-sankyo.eu/imprint/

All information posted by Daiichi Sankyo Europe on this channel is intended for non-US, non-Canada & non-UK visitors.

Section iconCompany Overview

Phone number
SIC Code
2834 - Pharmaceutical Preparations
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1899
Employees
1001-5000

Section iconFunding & Financials

  • $250M$500M

    Daiichi Sankyo Europe GmbH's revenue is estimated to be in the range of $250M$500M

Section iconFunding & Financials

  • $250M$500M

    Daiichi Sankyo Europe GmbH's revenue is estimated to be in the range of $250M$500M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.